Blood test may cut antibiotic time for sick newborns
NCT ID NCT03730636
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study looked at whether measuring a marker called procalcitonin in the blood can help doctors decide when to stop antibiotics in newborns with late-onset sepsis. Over 500 babies were included. The goal was to reduce antibiotic use by 30% without raising the risk of infection coming back or death. The approach could lead to safer, more targeted treatment for vulnerable infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Neonatology Bretonneau Hospital
Paris, Tours, 37044, France
Conditions
Explore the condition pages connected to this study.